Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
All people
Jessica Cirillo
Sort by Type
Date
Speaker
ePoster
P179
Treatment with Zavegepant offers improvements in pain severity over 48-hours when compared with Placebo – post hoc results from a randomized Placebo-controlled trial (BHV3500-301)
ePoster
P199
Examining trajectories of functional disability – a post-hoc analysis of Zavegepant
Further involvements
ePoster
P144
Characterisation and treatment of patients with menstrual migraine in real-world clinical practice
ePoster
P103
Characteristics of people with migraine using rimegepant in the Adelphi migraine Disease Specific Programme
TM
(DSP)
ePoster
P179
Treatment with Zavegepant offers improvements in pain severity over 48-hours when compared with Placebo – post hoc results from a randomized Placebo-controlled trial (BHV3500-301)
ePoster
P199
Examining trajectories of functional disability – a post-hoc analysis of Zavegepant
ePoster
P253
Characteristics of patients prescribed rimegepant vs. all patients seeking migraine care via telemedicine
ePoster
P288
Acute medication overuse in people with migraine from the 2022 European National Health & wellness survey
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy